The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Irinotecan and infusional 5-fluorouracil (mFOLFIRI) in patients with refractory advanced pancreas cancer (APC): A single institution experience.
 
Manojkumar Bupathi
No Relationships to Disclose
 
Daniel H. Ahn
Consulting or Advisory Role - Celltrion (I)
 
Kristen Keon Ciombor
Research Funding - Boston Biomedical; MedImmune; Pfizer
 
Christina Sing-Ying Wu
Consulting or Advisory Role - Bayer
Research Funding - Amgen
 
Sameh Mikhail
No Relationships to Disclose
 
Richard M. Goldberg
Honoraria - Baxter; Biothera; Immunocare Therapies; kanghong Pharma; Lilly; Momenta Pharmaceuticals; Novo Nordisk; Sanofi
Research Funding - Bayer (Inst); Immunomedics (Inst); Merck (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Baxter; Merck KGaA; Sanofi
 
Anne M. Noonan
No Relationships to Disclose
 
Julie Stephens
No Relationships to Disclose
 
Josh Reardon
No Relationships to Disclose
 
John L. Hays
Consulting or Advisory Role - Eisai
 
Tanios S. Bekaii-Saab
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech/Roche; Lilly; NCCN; Pfizer; Regeneron; Research to Practice; Sanofi; Sirtex Medical; Taiho Pharmaceutical
Other Relationship - Exelixis; Polaris